系统综述揭示EQ-5D最小重要差异随治疗类型变化并可能随基线评分升高而减小
该系统综述检索1990年1月至2023年3月八个电子数据库,纳入47篇文章,分析EQ-5D-3L、EQ-5D-5L指数和EQ VAS的基于锚定的最小重要差异(MID)估计值。改善评分的MID范围分别为-0.13至0.68、0.01至0.41和0.42至23.0;手术干预和较低基线评分与EQ指数更高MID相关,非线性多项式模型预测优于线性模型。作者建议使用基线评分校正和治疗类型特异的EQ-5D MID。
要点
- 手术干预和较低基线评分与EQ-5D指数更高MID相关,EQ VAS无此关联。
- 改善评分的MID范围:EQ-5D-3L -0.13至0.68,EQ-5D-5L 0.01至0.41,EQ VAS 0.42至23.0。
- 作者建议使用基线评分校正和治疗类型特异的EQ-5D MID。
核心结论
- EQ-5D指数评分的MID随基线评分和治疗类型变化,使用统一MID可能不合适。
- 作者建议使用基线评分校正和治疗类型特异的EQ-5D MID,并呼吁更多MID研究,尤其是评估健康恶化时。
研究设计与样本
- 系统检索八个电子数据库,时间范围为1990年1月至2023年3月。
- 共审查6786条记录,纳入47篇文章进行分析。
- 分析基线评分、评分变化类型(改善/恶化)、数据来源、价值集、疾病/状况、治疗类型(手术/非手术)和锚类型(临床 vs 自评)与MID估计值的关联。
- 使用线性和非线性回归模型开发MID预测公式。
主要发现
- 改善评分的MID范围:EQ-5D-3L为-0.13至0.68,EQ-5D-5L为0.01至0.41,EQ VAS为0.42至23.0。
- 手术干预和较低基线评分与EQ指数更高MID相关,但与EQ VAS无关。
- 非线性多项式模型在预测MID方面优于线性模型。
- 基于恶化评分的MID不足以进行定量合成(均值:EQ-5D-3L为-0.02;EQ-5D-5L为-0.04;EQ VAS为-6.5)。
关键数值与推荐
- 改善评分的MID范围:EQ-5D-3L -0.13至0.68,EQ-5D-5L 0.01至0.41,EQ VAS 0.42至23.0。
- 恶化评分的MID均值:EQ-5D-3L -0.02,EQ-5D-5L -0.04,EQ VAS -6.5。
临床怎么用
- 作者建议使用基线评分校正和治疗类型特异的EQ-5D MID。
- 作者呼吁更多MID研究,尤其是在评估健康恶化时。
局限性
- 基于恶化评分的MID不足以进行定量合成(均值:EQ-5D-3L为-0.02;EQ-5D-5L为-0.04;EQ VAS为-6.5)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To provide an updated summary of published anchor-based Minimally Important Difference (MID) estimates for the EQ-5D index and EQ visual analog scale (EQ VAS) scores and identify factors influencing those estimates. STUDY DESIGN AND SETTING: We systematically searched eight electronic databases from January 1990 to March 2023. We examined the association of baseline score, type of score change (improvement/worsening), data source, value set, disease/condition, treatment type (surgical/non-surgical), and type of anchor (clinical vs. self-rated) with MID estimates for the EQ-5D-3L and EQ-5D-5L indices, and EQ VAS. Significant variables were used to develop prediction formulas for MID by testing both linear and nonlinear regression models. RESULTS: Of 6786 records reviewed, 47 articles were included for analysis. MID ranges for improved scores were -0.13 to 0.68 (EQ-5D-3L), 0.01-0.41 (EQ-5D-5L), and 0.42-23.0 (EQ VAS). Surgical intervention and lower baseline scores were associated with higher MIDs for both the EQ indices but not for EQ VAS. The nonlinear polynomial model outperformed the linear model in predicting the MIDs. MIDs based on deteriorated scores were insufficient for quantitative synthesis (mean: -0.02 for EQ-5D-3L; -0.04 for EQ-5D-5L; and -6.5 for EQ VAS). CONCLUSION: This review revealed that the MID of EQ-5D index scores varies with baseline score and treatment type, indicating that use of a uniform MID may not be appropriate. We recommend using baseline score-adjusted and treatment type-specific EQ-5D MIDs, and call for more MID research, particularly in the context of assessing deterioration in health using this widely used generic health-status instrument.
引用
- Cheng LJ, Chen LA, Cheng JY, et al. Systematic review reveals that EQ-5D minimally important differences vary with treatment type and may decrease with increasing baseline score. J Clin Epidemiol. 2024. PMID: 39084578. doi:10.1016/j.jclinepi.2024.111487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。